Frankfurt: It has long been proven that people who follow a Mediterranean diet and
keep physically and mentally active are less likely to suffer from
dementia. Olives in particular appear to play a key role in this regard.
But just what are the substances contained in these small, oval fruit
that are so valuable? This is what a Hessen-based group of researchers
from the Goethe University Frankfurt, the Technical University (TU) of
Darmstadt and Darmstadt company N-Zyme BioTec GmbH intends to find out.
The three-year project “NeurOliv” has a project volume of 1.3 million
Euros and is funded by the Federal Ministry of Education and Research as
part of the high-tech initiative "KMU-innovativ Biochance".
This
collaboration combines a number of approaches, the initiative of which
came from N-Zyme BioTec GmbH. The aim is to use substances contained in
olives to develop new functional food for the ageing society, which will
protect against Alzheimer’s disease. “We want to test whether olive
polyphenols can even help to cure the disease. This is why we believe
our products also relate to the pharmaceutical sector”, says Dr. Joachim
Tretzel, Managing Director of N-Zyme BioTec GmbH. The high-tech
initiative of the German government was set up to fund small and
medium-sized enterprises.
The team, led by Prof. Heribert
Warzecha of the Department of Biology of TU Darmstadt, is examining the
development of new biotechnological processes designed to extract
specific plant substances. With the relevant genetic information,
bacterial cultures are said to help bring out substances in a pure and
defined form. “Our new techniques make it easier to extract substances
from olive leaves and significantly improve low yields“, explains
Warzecha. “When it comes to production, this means we aren’t dependent
on the seasonal harvesting of olives in growing areas”, adds Dr. Stefan
Marx, also Managing Director of N-Zyme BioTec.
The
“nutritional-neuroscience” working group of Dr. Gunter Eckert, food
chemist and private lecturer at the Goethe University Frankfurt (GU),
will test the effectiveness of these biotechnologically produced olive
substances. Firstly, olive substances will be tested in cell culture
models, which may protect against Alzheimer’s disease. “We focus on
changes to the power houses of nerve cells (mitochondria), which change
early on in Alzheimer’s disease”, says Eckert. The most active compounds
should then demonstrate in a mouse model of the disease that they can
improve brain function.
“We are testing the hypothesis that certain
polyphenols from olives slow down disease processes in the brain,
improve mitochondrial dysfunction and, as a result, provide evidence to
suggest they protect against Alzheimer’s disease”, explains
pharmacological expert Eckert, summarizing the objective of his
research. GU researchers have been awarded funding of 288,000 Euros for
the project. In another research project, Eckert is examining the
relationship between diet and exercise with regard to the development of
Alzheimer’s disease.